PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 6687623

[Computerized program for calculating the dose distribution generated by intracavitary linear sources of gamma radiation].

V F Minenko·A I Golubovskiĭ·I G Tarutin
View original source ↗Export metadata ↓

Abstract

One can achieve a high precision in the dosing of a session of intracavitary radiotherapy by rapid computerization of the treatment time that is necessary for obtaining a certain dose in a pathological focus taking account of an actual location of radiation sources in the process of irradiation. The authors have developed an algorithm and drawn up a program for computer ES-1022 to calculate a dose rate in any point of an irradiated volume from the system of gamma-radiation sources oriented arbitrarily in space. As part of a hard- and soft ware dosimetric complex, the above program provides for the calculation of the treatment time by a set dose; the time is necessary for supplying this dose to a tumor focus taking account of an actual location of radiation sources during a session of irradiation. The whole computer procedure from the moment of obtaining necessary anatomo-topographic information in the form of two x-ray pictures up to the output of an irradiation session time value and other information into the alpha-numeric printer takes 3-5 min. The program makes it possible to calculate dose distribution in any preset plane (up to 4 planes at a time) of an irradiated volume.

Explore related subjects

BrachytherapyComputersGamma RaysMathematicsRadiotherapy DosageSoftwareEnglish AbstractJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

V F Minenko, A I Golubovskiĭ, I G Tarutin. 1983. [Computerized program for calculating the dose distribution generated by intracavitary linear sources of gamma radiation].. https://pubmed.ncbi.nlm.nih.gov/6687623/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1996

Dose-volume histogram analysis of high dose rate intracavitary brachytherapy for uterine cervix cancer.

PURPOSE: We retrospectively analyzed the relationship between dose distribution and local control using a dose-volume histogram (DVH) in patients with cancer of the uterine cervix treated by definitive radiotherapy including intracavitary brachytherapy. METHODS AND MATERIALS: Twenty-five patients with squamous cell carcinoma of the uterine cervix who underwent definitive radiotherapy between August 1987 and April 1994 were selected for the present study. They included 15 patients with local control and 10 patients with local recurrence. In principle, these patients were treated with 50 Gy of external beam pelvic radiotherapy and a point A dose of 24 Gy, in four fractions, of intracavitary brachytherapy. The DVHs of tumor volumes were calculated by superimposing three-dimensional (3D) dose distributions on computed tomography (CT) images taken before brachytherapy. RESULTS: Differential DVHs revealed a tendency for the portion of the total tumor volume to which the delivered dose was low to be larger in patients with local recurrence. The tumor volumes and the absolute dose volumes of which the absorbed dose was less than 24 Gy [DV (< 24 Gy)] were significantly larger in patients with local recurrence than those in local control patients (p = 0.02 and 0.03, respectively). The percent DV (<24 Gy) was not significantly different in the two groups. In patients with larger tumor volume, the absolute DV (<24 Gy) was also larger and a strong linear correlation was noted between them. CONCLUSIONS: The analysis of dose distribution of brachytherapy using DVH was useful to evaluate the quality of dose distribution quantitatively. The absolute dose volume was considered more important than the percent dose volume for evaluation of the clinical outcome. Our study suggested that unfavorable dose distribution for the tumor volume in brachytherapy was one of the reasons of poor local control in patients with large tumor volume.

Brachytherapy↗
PubMed1996

Quality assurance in breast cancer brachytherapy: geographic miss in the interstitial boost treatment of the tumor bed.

PURPOSE: To assess the role of geographic misses in the interstitial boost treatment of breast cancer patients and to evaluate methods of optimizing breast implants in design, performance, and dosimetry. METHODS AND MATERIALS: During lumpectomy, the tumor excision sites of 89 patients were marked by five hemoclips. Postoperative radiographs demonstrated the clips' positions with respect to the extension of the surgical cavity, which was demarcated by air and hematoseroma. Twenty-seven selected patients received interstitial boosts to the tumor bed. The implant was first designed according to the clinical assumptions of the tumor bed's topography and then compared with the radiological findings. Prior to brachytherapy, the planning of the implant's dimension and the needle guidance was performed under simulator control. Dose distributions were first calculated following the Paris System and then electively optimized for the target volume by changing source positions and dwell times. RESULTS: Compared to clinical estimations, the radiological determination of the tumor bed's location revealed an overall potential of topographic errors of 51.8% (14 out of 27 patients), rising up to 78.5% in patients with large adipose breasts (11 out of 13 patients). This observation was due to a high mobility of the tissue, leading to varying tumor site projections at the time of mammography, surgery, and brachytherapy. In all patients, the presimulation of the implant resulted in an adequate coverage of the target volume. In 17 of the 27 treated patients, dose distributions were modified to achieve a higher dose delivery in zones where a higher residual tumor load was expected (boost-in-boost). CONCLUSION: Breast implants have a high potential of geographic misses that can be avoided by intraoperative clip demarcation. The delineation of the tumor bed allows for dose reports actually referring to the target volume and not to the implant system to be obtained. In addition, modern afterloading techniques offer possibilities of individual dose planning with regard to high risk subvolumes within the implanted tissue.

Brachytherapy↗